Abbott Reports Q4 Revenue Up 7.2% YoY to $10.97 Billion, Below Analyst Expectations

Gelonghui January 22 | Abbott announced its Q4 2024 financial results, with revenue increasing by 7.2% year-over-year to $10.97 billion, but falling short of the analysts' average estimate of $11.01 billion. Adjusted earnings per share were $1.34, meeting expectations. Sales in the medical device division reached $5.052 billion, a year-over-year increase of 13.7%.

The company expects that the adjusted earnings per share for the first quarter will be between $1.05 and $1.09, below the analysts' average estimate of $1.11; the adjusted earnings per share for 2025 will be between $5.05 and $5.25, with analysts' average estimate at $5.16.